Skip to content

Natural sugar in the management of type-II diabetes mellitus

Effects of natural sugar supplementation on blood glucose levels in patients with type-II diabetes mellitus

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2011/10/002039
Enrollment
25
Registered
2011-10-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- type-II diabetes mellitus

Interventions

Intervention1: Natural sugar: Information on the �Additive� that is blended with Natural Cane sugar to render it diabetic friendly: Ingredients like Fenugreek, Turmeric, Pepper, Dried ginger, Cinn

Sponsors

Sugen Life Sciences Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects whose fasting blood glucose levels in between 90 mg/dl and 200 mg/dl and normal in blood pressure and other biochemical parameters. Taking standard medication for the past three months

Exclusion criteria

Exclusion criteria: ? Diabetic patients currently under treatment for heart disease, cancer, post-surgical patients, tuberculosis and other chronic diseases. ? Subjects who are smokers, alcoholism, chewing of various tobacco products and usage of drugs ? Subjects who are sedentary/heavy physical activity, under weight and overweight/obesity ? Subjects who are bedridden for chronic diseases for prolonged time and kidney diseases and whose serum creatinine levels are 1.5 mg/dl ? Diabetes patients taking insulin (type-1 diabetes patients) ? Subjects who had cancer, AIDS, HIV, heart failure, major surgery in past 4 years ? Pregnant women

Design outcomes

Primary

MeasureTime frame
The primary outcome variables will be NS induced changes in fasting and post-prandial blood glucose levels.Timepoint: Once in a four weeks

Secondary

MeasureTime frame
I. Changes in serum concentrations of lipid profile (Total cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides and hemoglobin A1c). II. Changes in body weight and BMI. III. Incidence and severity of adverse events Timepoint: Once in a four weeks

Countries

India

Contacts

Public ContactINagaraju

Gnanaganga Ayurvedic Trust Hospital /Research Center

kanalakr@yahoo.com9291333655

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026